SCHEMBL6280011

SCHEMBL6280011

CCCCCC(N)CCC(C)CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.52
S1PR2 O95136 5/20 0.46
S1PR1 P21453 5/20 0.46
S1PR3 Q99500 5/20 0.46
S1PR4 O95977 4/20 0.46
PLA2G1B P04054 1/20 0.45
PLA2G2A P14555 1/20 0.45
SPHK1 Q9NYA1 2/20 0.43
TP53 P04637 2/20 0.42
ACE2 Q9BYF1 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LAP3 P28838 1/20 0.38
CYP2D6 P10635 2/20 0.36
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
THPO P40225 1/20 0.36
MTOR P42345 1/20 0.36
BLM P54132 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6285007 0.98 OPRM1 (0.50) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL21027578 0.96 OPRM1 (0.48) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL12948942 0.90 ACE2 (0.44) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL23252495 0.86 OPRM1 (0.46) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL22857601 0.86 ACE2 (0.53) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL6283485 0.83 ALDH1A1 (0.38) OPRM1ALDH1A1
SCHEMBL15477771 0.83 PLA2G1B (0.60) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL15477719 0.83 PLA2G1B (0.60) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL15477832 0.83 PLA2G1B (0.60) OPRM1S1PR2S1PR1S1PR3S1PR4
SCHEMBL15477740 0.83 PLA2G1B (0.60) OPRM1S1PR2S1PR1S1PR3S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6919291-B2 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2005-07-19 US disclosed
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2004-06-10 US disclosed
EP-1349653-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION ExxonMobil Chemical Patents Inc. (US) 2003-10-08 EP disclosed
WO-2002036639-A2 FLUORINATED ZWITTERIONIC COCATALYST ACTIVATORS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110631-A1 Fluorinated zwitterionic cocatalyst activators for olefin polymerization FZD7, FOS, COG4 OPRM1 59/4885S1PR2 3125/4885S1PR1 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.